Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications
Cancer Cell · 2026-01 · 44 (1) · 24-49
DOI: 10.1016/j.ccell.2025.12.009 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2026-01. Verfasst von Yunhe Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Genomics. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute, University of Texas MD Anderson Cancer Center.
Abstract (Originalsprache)
Spatial omics transforms our understanding of cancer by revealing how tumor cells and the microenvironment are organized, interact, and evolve within tissues. Here, we synthesize advances in spatial technologies that map tumor ecosystems with unprecedented fidelity. We highlighted analytical breakthroughs-including multimodal integration and emerging spatial foundation models-that resolve functional niches and spatial communities, converting spatial patterns into mechanistic insights. We summarize how spatially organized features, from immune hubs to microbiota and neural interfaces, shape tumor evolution and clinical outcomes. We then outline how spatial approaches illuminate precancer biology, metastatic adaptation, and therapy response. Bridging discovery and translation, we provide a practical roadmap for incorporating spatial readouts into clinically oriented study design. We conclude by discussing persistent challenges in standardization and scalability and how high-plex spatial discoveries may be distilled into scalable, AI-enabled, clinically deployable assays, positioning spatial omics as a cornerstone of next-generation predictive and precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houst…
Förderung
- NCI NIH HHS
- National Institutes of Health National Cancer Institute
- University of Texas MD Anderson Cancer Center
- Break Through Cancer
Zitieren
APA
Liu, Y., Dai, Y., & Wang, L. (2026). Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell, 44(1), 24-49. https://doi.org/10.1016/j.ccell.2025.12.009
Vancouver
Liu Y, Dai Y, Wang L. Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell. 2026;44(1):24-49. doi:10.1016/j.ccell.2025.12.009
BibTeX
@article{Liu2026,
author = {Liu, Yunhe and Dai, Yibo and Wang, Linghua},
title = {Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {1},
pages = {24--49},
doi = {10.1016/j.ccell.2025.12.009}
}
EUVIMED